Today: 19 June 2026
Rocket Lab gets Pentagon nod; SpaceX IPO talk fuels sector

Rocket Lab gets Pentagon nod; SpaceX IPO talk fuels sector

LONG BEACH, California, May 27, 2026, 04:18 PDT

  • Rocket Lab cleared a major milestone for a U.S. missile-warning satellite program, allowing its roughly $816 million award from the Space Development Agency to stay on track.
  • Rocket Lab gave the update after picking up a $90 million U.S. Space Force satellite contract and wrapping up its buyout of Motiv Space Systems.
  • Rocket Lab rose roughly 5.5% in premarket trading as public space names moved with the buzz around SpaceX’s proposed IPO.

Rocket Lab said Wednesday it cleared a system requirements review for the Space Development Agency’s Tracking Layer Tranche 3 constellation. The review is a technical milestone for the satellites, which are designed to detect and track advanced missile threats.

The System Requirements Review, or SRR, clears a design to move ahead once customer needs are checked off. Rocket Lab said it will use its Lightning satellite, Phoenix infrared sensor, plus its own power, propulsion, avionics, and ground control systems in the program.

Timing is in focus. Rocket Lab wants investors to see it as more than a small-launch firm. The company is pitching itself as a prime contractor, with responsibility for delivering full U.S. national security space missions.

Shares last traded at $143.20 in premarket, up 5.5%. SpaceX’s planned IPO, which Reuters has reported may value Elon Musk’s company at $1.75 trillion, is drawing more focus to listed space stocks.

Rocket Lab has reached its latest milestone less than a week after landing a $90 million contract from the U.S. Space Force’s Space Systems Command. The company is set to design, build, integrate and operate two geostationary-orbit satellites carrying the Heimdall space domain awareness payload. Geostationary orbit keeps the satellite fixed over one spot on Earth; space domain awareness is for tracking objects and risks in orbit.

Rocket Lab USA president Brad Clevenger said clearing the review proved the company’s “technical readiness” and pointed to its vertically integrated model as able to give “speed, resilience, and performance” for national security work. GlobeNewswire

Rocket Lab on Tuesday said it finished buying Motiv Space Systems, which is now called Rocket Lab Robotics. Motiv adds a 50-person team in Pasadena, California, and tech used on NASA’s Mars Perseverance rover and CADRE lunar robots, plus hardware for spacecraft like solar array drives and antenna gimbals. “This gives Rocket Lab everything needed to lead the next era of Mars exploration,” CEO Sir Peter Beck said. GlobeNewswire

Rocket Lab’s numbers are climbing. The company put up first-quarter revenue of $200.3 million, 63.5% higher than the same period last year, with a $2.2 billion backlog. Rocket Lab signed 31 Electron and HASTE launch deals and another five for Neutron in the quarter. HASTE is its hypersonic test vehicle, and Neutron is the company’s planned medium-lift rocket.

SpaceX is still the name everyone watches. Reuters said SpaceX could go public as soon as June 12, with a roadshow planned for June 4. FTSE Russell said after the IPO, SpaceX might get fast-tracked into big U.S. and global indexes.

Starship’s recent test flight gave investors something to stay interested in, but it was far from flawless. According to Reuters, the new Starship version released dummy satellites and splashed down under control, but the Super Heavy booster missed its landing. Mark Vena, CEO at SmartTech Research, said SpaceX still needs to show the rocket “moving in the right direction.” James Bruegger from Seraphim Space said the main reward is with full reusability. Reuters

Rocket Lab is moving closer to established defense contractors with its growing government work. The Space Development Agency named Lockheed Martin, Rocket Lab and Northrop Grumman in December as selected teams for Tranche 3 of its missile-warning and tracking project, a $3.5 billion order for 72 satellites.

But there isn’t much margin for error here. Rocket Lab reported a $45.0 million net loss in the first quarter. The company also filed an SEC prospectus that lets it sell up to $3 billion of common stock through an at-the-market program, meaning shares can be issued over time. The filing flagged that more shares could cut earnings per share and push down the stock price.

Execution is the next hurdle: Rocket Lab has to deliver missile-defense satellites, fold in Motiv smoothly, and get Neutron to the launch pad. The company said this month Neutron is still expected to fly for the first time later this year, a statement that puts Rocket Lab up against SpaceX’s production pace and its own backlog.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Credo Technology Group Holding (CRDO) Stock Seen 109.1% Overvalued After Strong Price Rally
    June 18, 2026, 9:56 PM EDT. Credo Technology Group Holding (CRDO) stock surged 162.89% over three months, reaching a high of $271.83 per share. Despite strong momentum and a 3-year return exceeding 10 times initial value, analysts at Simply Wall St rate the stock as 109.1% overvalued with a fair value of $130.00. This significant gap reflects market expectations for future growth in AI connectivity and product pipelines priced into shares. While profitability remains solid, risks include delays in product launches through 2027-28 and shifts in AI infrastructure spending. Investors are urged to weigh the company's rapid growth against these uncertainties before investing.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Nokia Oyj Stock’s AI Run Gets Fresh Wall Street Jolt as Targets Rise
Previous Story

Nokia stock hits fresh high on AI interest

Plug Power Shares End Flat After Volatile Trading Ahead of Holiday
Next Story

Plug Power Shares On Watch Ahead of U.S. Market Open

Go toTop